Oklahoma boy hears for the first time thanks to cochlear implants

A four-year-old boy from Oklahoma, born with congenital CMV, experiences the world of sound for the first time after ...
The Manila Times

Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1

Evaxion’s AI-Immunology™ platform has discovered novel CMV antigens that significantly reduce viral infection in preclinical models EVX-V1 is a next-generation, multi-component vaccine program ...
Neurology Advisor

Universal Congenital Cytomegalovirus Screening IDs Newborns at Risk for Hearing Loss

One-third of congenital cytomegalovirus-related hearing loss would be missed without universal screening programs.
Medical Xpress

Impact of universal congenital cytomegalovirus screening on early detection of newborn hearing loss revealed

A comprehensive eight-year study examining audiological outcomes of newborns screened for congenital cytomegalovirus (cCMV) through universal screening demonstrates the critical importance of early ...
Labroots

Congenital Cytomegalovirus: Newborn Screening Updates

Congenital cytomegalovirus (cCMV) is the most common infectious cause of birth defects and non-genetic hearing loss in the United States, yet it remains underdiagnosed due to the absence of universal ...
Fort Collins Coloradoan

Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint

CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company’s ...